These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 17593294)

  • 1. Phage display-based molecular methods in immunohematology.
    Siegel DL
    Transfusion; 2007 Jul; 47(1 Suppl):89S-94S. PubMed ID: 17593294
    [No Abstract]   [Full Text] [Related]  

  • 2. Overview of molecular methods in immunohematology.
    Reid ME
    Transfusion; 2007 Jul; 47(1 Suppl):10S-6S. PubMed ID: 17593280
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of the Food and Drug Administration in the use of molecular techniques in immunohematology.
    Kochman SA
    Transfusion; 2007 Jul; 47(1 Suppl):3S-9S. PubMed ID: 17593279
    [No Abstract]   [Full Text] [Related]  

  • 4. Proceedings of a workshop on molecular methods in immunohematology, September 25-26, 2006, Bethesda, Maryland, USA.
    Transfusion; 2007 Jul; 47(1 Suppl):S1-100S. PubMed ID: 17703548
    [No Abstract]   [Full Text] [Related]  

  • 5. Phage display for engineering and analyzing protein interaction interfaces.
    Sidhu SS; Koide S
    Curr Opin Struct Biol; 2007 Aug; 17(4):481-7. PubMed ID: 17870470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of monoclonal antibody fragments from phage display libraries.
    Arbabi-Ghahroudi M; Tanha J; MacKenzie R
    Methods Mol Biol; 2009; 502():341-64. PubMed ID: 19082566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-affinity peptide-based collagen targeting using synthetic phage mimics: from phage display to dendrimer display.
    Helms BA; Reulen SW; Nijhuis S; de Graaf-Heuvelmans PT; Merkx M; Meijer EW
    J Am Chem Soc; 2009 Aug; 131(33):11683-5. PubMed ID: 19642697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Where are we, and where are we going, with DNA-based approaches in immunohematology? Is serology finished?
    Garratty G
    Transfusion; 2007 Jul; 47(1 Suppl):1S-2S. PubMed ID: 17593278
    [No Abstract]   [Full Text] [Related]  

  • 9. Phage peptide display.
    Newton J; Deutscher SL
    Handb Exp Pharmacol; 2008; (185 Pt 2):145-63. PubMed ID: 18626602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of immunogenic polypeptides from a Mycoplasma hyopneumoniae genome library by phage display.
    Kügler J; Nieswandt S; Gerlach GF; Meens J; Schirrmann T; Hust M
    Appl Microbiol Biotechnol; 2008 Sep; 80(3):447-58. PubMed ID: 18636254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease substrate site predictors derived from machine learning on multilevel substrate phage display data.
    Chen CT; Yang EW; Hsu HJ; Sun YK; Hsu WL; Yang AS
    Bioinformatics; 2008 Dec; 24(23):2691-7. PubMed ID: 18974075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple method to remove hemoglobin from antiserum.
    Sagisaka K; Iwasa M
    Tohoku J Exp Med; 1976 Sep; 120(1):97-8. PubMed ID: 785699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Screening peptides binding specifically to large intestinal cancer LoVo cells from phage random peptide library].
    Liao KX; Yao XQ; Wu CT; Lin F; Wu WL; Zeng SD; Luo YQ; Lei ST
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):986-90. PubMed ID: 18583245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Construction and preliminary panning of Fab phage display antibody library against respiratory syncytial virus].
    Wang ZH; Zhang GC; Li AM
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Dec; 10(6):681-5. PubMed ID: 19102829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragment-based ligand discovery meets phage display.
    Erlanson DA
    ACS Chem Biol; 2007 Dec; 2(12):779-82. PubMed ID: 18154264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mRNA-display-based selections for proteins with desired functions: a protease-substrate case study.
    Valencia CA; Cotten SW; Dong B; Liu R
    Biotechnol Prog; 2008; 24(3):561-9. PubMed ID: 18471027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of protein properties on display efficiency using the M13 phage display system.
    Imai S; Mukai Y; Takeda T; Abe Y; Nagano K; Kamada H; Nakagawa S; Tsunoda S; Tsutsumi Y
    Pharmazie; 2008 Oct; 63(10):760-4. PubMed ID: 18972841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of bioactive peptides by biological libraries.
    Mersich C; Jungbauer A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(2):160-70. PubMed ID: 17644452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using T7 phage display to select GFP-based binders.
    Dai M; Temirov J; Pesavento E; Kiss C; Velappan N; Pavlik P; Werner JH; Bradbury AR
    Protein Eng Des Sel; 2008 Jul; 21(7):413-24. PubMed ID: 18469345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of C10 biotinylated camptothecin (CPT-10-B) binding peptides using T7 phage display screen on a QCM device.
    Takakusagi Y; Takakusagi K; Kuramochi K; Kobayashi S; Sugawara F; Sakaguchi K
    Bioorg Med Chem; 2007 Dec; 15(24):7590-8. PubMed ID: 17897832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.